What Does Ultrasound Show? A Quality Inspector’s Take on Imaging, Oxygen Therapy, and Lab Diagnostics

What You'll Find Here

If you're involved in purchasing or specifying medical equipment—whether it's a portable oxygen concentrator, a hematology analyzer, or ultrasound for your clinic—you probably have questions that aren't covered in the product brochure. This FAQ-based article answers the most common (and a few less common) questions I hear from clinicians and procurement teams. I'm a quality compliance manager, not a radiologist or pulmonologist, so I'll stay in my lane: the practical, verifiable side of equipment selection, specification, and performance.

1. What does ultrasound show? The simple answer and the blind spot.

Everyone knows ultrasound shows images of soft tissues, organs, and blood flow in real-time. That's the obvous answer. But the question most buyers miss is: how consistent is the image quality across applications?

From my perspective, what ultrasound shows depends heavily on three things: the transducer quality, the software processing algorithms, and—critically—the operator's skill. Most procurement RFPs focus on frequency ranges and probe types. What they overlook is how the machine handles edge cases: obese patients, deep tissue imaging, or motion artifacts from an uncooperative patient.

In a Q3 2024 audit, I reviewed 12 ultrasound units across three vendors. The specs were nearly identical on paper. In blind image testing with our radiology team, the perceived diagnostic confidence varied by 22% between the ‘best’ and ‘worst’ performer (based on a scoring rubric we developed internally). That's a gap specs alone won't reveal.

I'm not a sonographer, so I can't speak to interpreting specific findings. What I can tell you is: if you're buying ultrasound, insist on a live demo with your typical patient population.

2. Portable oxygen concentrators: What's the real trade-off between size and performance?

The assumption is that smaller concentrators deliver less oxygen. That's technically true, but the causation isn't as straightforward as people think. People think smaller size causes lower output. Actually, lower battery capacity and smaller compressors cause both size constraints and output limits. The relationship is mediated by engineering choices, not physics alone.

For a quality inspector, the most frustrating part of portable oxygen concentrators is the lack of standardization in how manufacturers rate ‘continuous flow’ versus ‘pulse dose’ settings—you'd think liters per minute would mean the same across brands, but effective oxygen delivery varies significantly because of different algorithms.

Three things to check before purchasing:

1. Battery life at your required flow rate—not the manufacturer's ‘typical use’ claim.
2. Weight with full battery—the difference between ‘portable’ and ‘wearable’ is often 5+ pounds.
3. Serviceability—can your biomed team replace the compressor? Some units are disposable after 5,000 hours.

Prices for portable oxygen concentrators range from $1,200 to $4,500 (based on major medical distributor quotes, March 2025; verify current pricing). The $3,300 delta isn't always justified by performance—sometimes it's brand positioning.

3. Hematology analyzers: Why do identical specs produce different results?

Most buyers focus on throughput (samples per hour) and parameters measured (CBC with differential, etc.). The question everyone asks is “how many parameters does it measure?” The question they should ask is “how does it handle abnormal samples in terms of flagging accuracy and no-result rate?”

In a blind test I ran in 2024, I compared three hematology analyzers from different manufacturers using 50 pre-characterized blood samples. All three claimed 22-parameter CBC. The variance in flagged abnormal results was 15% between the most and least accurate unit—meaning one machine would flag a sample as needing manual review while another would report normal. That's a patient safety issue disguised as a spec sheet match.

Not ideal, but workable: you can mitigate this by running a parallel validation with your lab's retrospective samples before committing to a purchase. The cost of rerunning samples adds up fast—literally hundreds of dollars per week in reagents and tech time.

4. Can a single ultrasound machine serve both outpatient OB/GYN and hospital radiology?

Possible? Yes. Smart? Usually not.

This worked for a community hospital chain I audited in early 2024. Their rationale was cost savings: one $180,000 ultrasound system instead of two dedicated units. The reality: the OB/GYN team wanted high-frequency transvaginal probes and 3D rendering; the radiology department needed deep abdominal imaging with contrast harmonics. The compromise machine did neither exceptionally well. Within 6 months, they purchased a second unit anyway—total cost $320,000 instead of the original $240,000 for two optimized systems.

The lesson: don't save money on the wrong spec. The cost of compromise shows up in frustrated clinicians and scheduling bottlenecks, not in the purchase order.

I can only speak to my experience with mid-size hospital systems. If you're a standalone clinic with lower volume, the calculus might be different—shared equipment with flexible scheduling could work fine.

5. What's the real difference between a $1,000 portable oxygen concentrator and a $4,000 one?

Not as much as you'd think—in terms of raw oxygen output. But in terms of consistency, durability, and support, the gap is significant.

In our Q1 2024 quality audit, we tested 5 portable oxygen concentrators across price brackets. The budget unit ($1,200) delivered the advertised flow rate—for about 3 hours. Then the battery degraded, and output dropped 18%. The premium unit ($3,800) maintained output within 5% of specification for its entire 8-hour battery life.

From a brand perception standpoint: when a patient receives a device that fails mid-trip, they don't blame the manufacturer—they blame the hospital or DME provider who supplied it. Upgrading to a reliable unit increased our customer satisfaction scores for home respiratory services by 34% (internal metric, 2024).

6. What does ultrasound show that MRI cannot—and vice versa?

This gets into radiology territory, which isn't my expertise. I'd recommend consulting a board-certified radiologist for imaging modality comparisons. But from a procurement perspective, I can share what I've observed in equipment justification meetings:

• Ultrasound is preferred for real-time guidance (biopsies, injections) and soft tissue evaluation where radiation is a concern (pregnancy, pediatrics).
• MRI provides superior soft tissue contrast for certain pathologies but costs 10-20x more per scan and has longer acquisition times.

The real quality question: do you have the right transducer and software for your specific application needs? Too many departments buy a ‘general imaging’ ultrasound and then wonder why their MSK or vascular studies are suboptimal.

7. Hematology analyzer calibration: How often is enough?

Manufacturers recommend calibration every 6-12 months. In practice, it depends on your sample volume and population mix. A high-volume lab processing 500 samples per day at a tertiary care hospital will drift faster than a clinic running 50.

Never expected the biggest factor to be reagent lot changes. Turns out switching between manufacturers’ reagent lots (even from the same supplier) can shift results by 3-5% for certain parameters. We now run a minimum of 20 patient samples in parallel whenever we change lot numbers, and we adjust our quality control limits reactively.

To some extent, manufacturers' recommended calibration intervals are designed to minimize liability, not to optimize cost. If your internal QC is tight, you can stretch intervals—but only if you have the data to back it up.

8. The one question no one asks about portable oxygen concentrators

Everyone asks about flow rates, battery life, and weight. Almost no one asks: what happens when the device fails?

In 2022, we had a batch of 200 portable concentrators where the internal pressure sensor had a median time-to-failure of 14 months—just past the warranty. The vendor claimed it was ‘within industry standard.’ We rejected their response. Now every contract we sign includes a specific MTBF (mean time between failures) requirement and a penalty clause for non-compliance.

The most frustrating part: the sensor cost $12 to replace. The logistics of managing 150 warranty claims across a distributed patient population? Easily $50,000 in administrative overhead plus patient dissatisfaction.

Worse than expected? Yes. A lesson learned the hard way? Absolutely.